SUBSCRIBE
SUBSCRIBE
News   Business

Acorda Therapeutics MS Walking Drug Sales Shine; Loss Narrows

August 3, 2010 | 
1 min read
NEW YORK Aug 3 (Reuters) - Acorda Therapeutics Inc (ACOR.O) reported second-quarter sales that were double Wall Street expectations for its new Ampyra drug to improve walking in multiple sclerosis patients.
Earnings
MORE ON THIS TOPIC
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Generate’s IPO Could Reach $425M, Largest Raise Yet
February 24, 2026
 · 
5 min read
 · 
Tristan Manalac
Manual worker with protective work gloves holding a yellow safety helmet on a yellow and orange background with copy space and reflections. Concept of workplace security.
Manufacturing
AbbVie Backs Obesity Push With $380M API Production Expansion Project in Illinois
February 24, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Collage image of people arms gloves hold equipment hit hammer cut saw nail gun isolated on creative white background.
Executive appointments
Merck Reorganizes Human Health Work Into Two New Units
February 23, 2026
 · 
1 min read
 · 
Annalee Armstrong
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
 · 
4 min read
 · 
Annalee Armstrong